XOMA Royalty (XOMA) Total Debt Growth (3y) (2013 - 2024)
XOMA Royalty (XOMA) Total Debt Growth (3y) (2013 - 2024) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Total Debt Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
6.94% |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
XOMA Royalty |
5.52 Mn |
-60.56 Mn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2024 |
85.66% |
| Dec 31, 2023 |
81.20% |
| Mar 31, 2021 |
8.97% |
| Dec 31, 2020 |
12.69% |
| Sep 30, 2020 |
27.88% |
| Jun 30, 2020 |
3.73% |
| Mar 31, 2020 |
5.79% |
| Dec 31, 2019 |
-9.24% |
| Sep 30, 2019 |
-10.26% |
| Jun 30, 2019 |
-17.61% |
| Mar 31, 2019 |
-21.26% |
| Dec 31, 2018 |
-22.70% |
| Sep 30, 2018 |
-23.17% |
| Jun 30, 2018 |
-32.36% |
| Mar 31, 2018 |
-32.41% |
| Dec 31, 2017 |
-25.55% |
| Sep 30, 2017 |
-26.85% |
| Jun 30, 2017 |
-10.06% |
| Mar 31, 2017 |
-11.75% |
| Dec 31, 2016 |
1.74% |
